Background: Sun exposure has consistently been associated with multiple sclerosis (MS) onset, but case samples are predominantly relapse-onset MS (ROMS), and risk estimates have rarely been reported separately for ROMS and progressive-onset MS (POMS). We aimed to determine whether sun exposure prior to disease onset was associated with POMS and whether the effect differed between POMS and ROMS. Methods: This nationwide case-control study included 153 POMS cases, 204 incident ROMS cases, and 558 community controls with data from two separate datasets: the PPMS Study (2015–2021) and the Ausimmune Study (2003–2006). Information on time spent in the sun before the first MS symptom, skin phenotype, and sun protection behavior was collected. Satellite data on ambient ultraviolet radiation (UVR) were used to calculate cumulative UVR dose. Unconditional logistic regression was used with adjustment for covariates. Results: There were consistent dose-response associations, with higher levels of UVR exposure associated with a reduced risk of POMS, both for leisure-time and occupational UVR from age 6 to symptom onset. Associations were overall stronger for POMS than ROMS. For example, cumulative leisure-time UVR dose (per 100 kJ/m2 increment) was associated with POMS (aOR 0.93, 95% CI: 0.91–0.95) and the association was slightly weaker for ROMS (aOR 0.96, 95% CI: 0.94–0.99) for age 6 to symptom onset (test for interaction p < 0.001). Conclusions: Low levels of sun exposure, throughout the whole lifespan, are associated with an increased risk of POMS and ROMS onset. The sun effects are usually stronger for POMS than ROMS.

1.
Klineova
S
,
Lublin
FD
.
Clinical course of multiple sclerosis
.
Cold Spring Harb Perspect Med
.
2018
;
8
(
9
):
a028928
.
2.
Lublin
FD
,
Reingold
SC
,
Cohen
JA
,
Cutter
GR
,
Sørensen
PS
,
Thompson
AJ
, et al
.
Defining the clinical course of multiple sclerosis: the 2013 revisions
.
Neurology
.
2014
;
83
(
3
):
278
86
.
3.
McKay
KA
,
Kwan
V
,
Duggan
T
,
Tremlett
H
.
Risk factors associated with the onset of relapsing-remitting and primary progressive multiple sclerosis: a systematic review
.
BioMed Res Int
.
2015
;
2015
:
817238
.
4.
Rzepinski
L
,
Zawadka-Kunikowska
M
,
Maciejek
Z
,
Newton
JL
,
Zalewski
P
.
Early clinical features, time to secondary progression, and disability milestones in polish multiple sclerosis patients
.
Medicina
.
2019
;
55
(
6
):
232
.
5.
McGinley
MP
,
Goldschmidt
CH
,
Rae-Grant
AD
.
Diagnosis and treatment of multiple sclerosis: a review
.
JAMA
.
2021
;
325
(
8
):
765
79
.
6.
Zarghami
A
,
Li
Y
,
Claflin
SB
,
Van Der Mei
I
,
Taylor
BV
.
Role of environmental factors in multiple sclerosis
.
Expert Rev Neurother
.
2021
;
21
(
12
):
1389
408
.
7.
Goris
A
,
Vandebergh
M
,
McCauley
JL
,
Saarela
J
,
Cotsapas
C
.
Genetics of multiple sclerosis: lessons from polygenicity
.
Lancet Neurol
.
2022
;
21
(
9
):
830
42
.
8.
Kiselev
I
,
Bashinskaya
V
,
Baulina
N
,
Kozin
M
,
Popova
E
,
Boyko
A
, et al
.
Genetic differences between primary progressive and relapsing-remitting multiple sclerosis: the impact of immune-related genes variability
.
Mult Scler Relat Disord
.
2019
;
29
:
130
6
.
9.
Jia
X
,
Madireddy
L
,
Caillier
S
,
Santaniello
A
,
Esposito
F
,
Comi
G
, et al
.
Genome sequencing uncovers phenocopies in primary progressive multiple sclerosis
.
Ann Neurol
.
2018
;
84
(
1
):
51
63
.
10.
Horwitz
H
,
Ahlgren
B
,
Naerum
E
.
Effect of occupation on risk of developing MS: an insurance cohort study
.
BMJ Open
.
2013
;
3
(
6
):
e002894
.
11.
Sabel
CE
,
Pearson
JF
,
Mason
DF
,
Willoughby
E
,
Abernethy
DA
,
Taylor
BV
.
The latitude gradient for multiple sclerosis prevalence is established in the early life course
.
Brain
.
2021
;
144
(
7
):
2038
46
.
12.
Campbell
JA
,
Simpson
S
,
Ahmad
H
,
Taylor
BV
,
van der Mei
I
,
Palmer
AJ
.
Change in multiple sclerosis prevalence over time in Australia 2010–2017 utilising disease-modifying therapy prescription data
.
Mult Scler
.
2020
;
26
(
11
):
1315
28
.
13.
McDonald
JJ
,
Weller
B
,
O’Neil
M
,
Waters
C
,
O’Riordan
J
;
Scottish MS Register Study Collaborators
.
Latitudinal variation in MS incidence in Scotland
.
Mult Scler Relat Disord
.
2019
;
32
:
116
22
.
14.
Tremlett
H
,
Zhu
F
,
Ascherio
A
,
Munger
KL
.
Sun exposure over the life course and associations with multiple sclerosis
.
Neurology
.
2018
;
90
(
14
):
e1191
9
.
15.
Lucas
RM
,
Ponsonby
AL
,
Dear
K
,
Valery
PC
,
Pender
MP
,
Taylor
BV
, et al
.
Sun exposure and vitamin D are independent risk factors for CNS demyelination
.
Neurology
.
2011
;
76
(
6
):
540
8
.
16.
Espinosa-Ramirez
G
,
Ordonez
G
,
Flores-Rivera
J
,
Sotelo
J
.
Sunlight exposure and multiple sclerosis in a tropical country
.
Neurol Res
.
2014
;
36
(
7
):
647
50
.
17.
van der Mei
IA
,
Ponsonby
AL
,
Dwyer
T
,
Blizzard
L
,
Simmons
R
,
Taylor
BV
, et al
.
Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study
.
BMJ
.
2003
;
327
(
7410
):
316
.
18.
Hart
PH
,
Jones
AP
,
Trend
S
,
Cha
L
,
Fabis-Pedrini
MJ
,
Cooper
MN
, et al
.
A randomised, controlled clinical trial of narrowband UVB phototherapy for clinically isolated syndrome: the PhoCIS study
.
Mult Scler J Exp Transl Clin
.
2018
;
4
(
2
):
2055217318773112
.
19.
Waubant
E
,
Lucas
R
,
Mowry
E
,
Graves
J
,
Olsson
T
,
Alfredsson
L
, et al
.
Environmental and genetic risk factors for MS: an integrated review
.
Ann Clin Transl Neurol
.
2019
;
6
(
9
):
1905
22
.
20.
Taylor
BV
,
Pearson
JF
,
Clarke
G
,
Mason
DF
,
Abernethy
DA
,
Willoughby
E
, et al
.
MS prevalence in New Zealand, an ethnically and latitudinally diverse country
.
Mult Scler
.
2010
;
16
(
12
):
1422
31
.
21.
Hedström
AK
,
Hillert
J
,
Olsson
T
,
Alfredsson
L
.
Factors affecting the risk of relapsing-onset and progressive-onset multiple sclerosis
.
J Neurol Neurosurg Psychiatry
.
2021
;
92
(
10
):
1096
102
.
22.
Lucas
R
,
Ponsonby
AL
,
McMichael
A
,
van der Mei
I
,
Chapman
C
,
Coulthard
A
, et al
.
Observational analytic studies in multiple sclerosis: controlling bias through study design and conduct. The Australian Multicentre Study of Environment and Immune Function
.
Mult Scler
.
2007
;
13
(
7
):
827
39
.
23.
Polman
CH
,
Reingold
SC
,
Banwell
B
,
Clanet
M
,
Cohen
JA
,
Filippi
M
, et al
.
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
.
Ann Neurol
.
2011
;
69
(
2
):
292
302
.
24.
Li
Y
,
Saul
A
,
Taylor
B
,
Ponsonby
AL
,
Simpson-Yap
S
,
Blizzard
L
, et al
.
Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies
.
J Neurol
.
2024
;
271
(
1
):
472
85
.
25.
King
L
,
Xiang
F
,
Swaminathan
A
,
Dear
K
,
Harrison
SL
,
van der Mei
I
, et al
.
Validation of sun exposure reported annually against interim self-report and daily sun diaries
.
Photochem Photobiol
.
2017
;
93
(
5
):
1294
302
.
26.
Lucas
RM
,
Ponsonby
AL
,
Dear
K
,
Taylor
BV
,
Dwyer
T
,
McMichael
AJ
, et al
.
Associations between silicone skin cast score, cumulative sun exposure, and other factors in the ausimmune study: a multicenter Australian study
.
Cancer Epidemiol Biomarkers Prev
.
2009
;
18
(
11
):
2887
94
.
28.
Taylor
BV
,
Lucas
RM
,
Dear
K
,
Kilpatrick
TJ
,
Pender
MP
,
van der Mei
IAF
, et al
.
Latitudinal variation in incidence and type of first central nervous system demyelinating events
.
Mult Scler
.
2010
;
16
(
4
):
398
405
.
29.
Simpson
S
,
Wang
W
,
Otahal
P
,
Blizzard
L
,
Van Der Mei
IAF
,
Taylor
BV
.
Latitude continues to be significantly associated with the prevalence of multiple sclerosis: an updated meta-analysis
.
J Neurol Neurosurg Psychiatry
.
2019
;
90
(
11
):
1193
200
.
30.
Webb
P
,
Bain
C
,
Page
A
.
Essential Epidemiology: an introduction for students and Health professionals
. 4 ed.
Cambridge University Press
;
2019
.
31.
Freedman
DM
,
Dosemeci
M
,
Alavanja
MC
.
Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case-control study based on death certificates
.
Occup Environ Med
.
2000
;
57
(
6
):
418
21
.
32.
Westberg
M
,
Feychting
M
,
Jonsson
F
,
Nise
G
,
Gustavsson
P
.
Occupational exposure to UV light and mortality from multiple sclerosis
.
Am J Ind Med
.
2009
;
52
(
5
):
353
7
.
33.
van der Mei
IA
,
Blizzard
L
,
Ponsonby
AL
,
Dwyer
T
.
Validity and reliability of adult recall of past sun exposure in a case-control study of multiple sclerosis
.
Cancer Epidemiol Biomarkers Prev
.
2006
;
15
(
8
):
1538
44
.
34.
Hart
PH
,
Norval
M
.
More than effects in skin: ultraviolet radiation-induced changes in immune cells in human blood
.
Front Immunol
.
2021
;
12
:
694086
.
35.
Hart
PH
,
Lucas
RM
,
Booth
DR
,
Carroll
WM
,
Nolan
D
,
Cole
JM
, et al
.
Narrowband UVB phototherapy for clinically isolated syndrome: a trial to deliver the benefits of vitamin D and other UVB-induced molecules
.
Front Immunol
.
2017
;
8
:
3
.
36.
Trend
S
,
Jones
AP
,
Cha
L
,
Cooper
MN
,
Geldenhuys
S
,
Fabis-Pedrini
MJ
, et al
.
Short-term changes in frequencies of circulating leukocytes associated with narrowband UVB phototherapy in people with clinically isolated syndrome
.
Sci Rep
.
05 28 2019
;
9
(
1
):
7980
.
37.
Weideman
AM
,
Tapia-Maltos
MA
,
Johnson
K
,
Greenwood
M
,
Bielekova
B
.
Meta-analysis of the age-dependent efficacy of multiple sclerosis treatments
.
Front Neurol
.
2017
;
8
:
577
.
38.
Yong
HYF
,
Yong
VW
.
Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis
.
Nat Rev Neurol
.
2022
;
18
(
1
):
40
55
.
You do not currently have access to this content.